Loading…

Edwards Lifesciences has increased its investment in a new manufacturing facility in Limerick, Ireland from €80 million to over €160 million. The plant will produce medical devices for structural heart disease and is expected to open by 2021, employing 600 people.
“We are proud to break ground today on a modern, state-of-the-art facility in Ireland that will serve as an important addition to our global supply chain to enable global delivery of our high-quality, life-saving heart valve therapies.”rte.ie
Summarized from public sources; check the original articles before acting on it.